Early-onset parkinsonism with dystonia. Clinical and biochemical differences from hereditary progressive dystonia or DOPA-responsive dystonia.
Furukawa
Y
Y
Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
Mizuno
Y
Y
Narabayashi
H
H
D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001708:Biopterins / Q000031:analogs & derivatives / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D004421:Dystonia / Q000150:complications / Q000235:genetics / Q000503:physiopathology*; D005260:Female; D008040:Genetic Linkage; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D019798:Neopterin; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D014202:Tremor / Q000503:physiopathology
D000978:Antiparkinson Agents; D001708:Biopterins; D007980:Levodopa; D019798:Neopterin